Reduction in albuminuria with dapagliflozin cannot be predicted by baseline clinical characteristics or changes in most other risk markers

By Hiddo J L Heerspink, C David Sjöström, Silvio E Inzucchi, Melissa K Hallow, Valerie A Cain, Peter Rossing, Bergur V Stefansson and Peter Sartipy

Topics: /dk/atira/pure/researchoutput/pubmedpublicationtype/D016428, Journal Article

Publisher: 'Wiley'

Year: 2019

DOI identifier: 10.1111/dom.13579

OAI identifier: oai:pure.atira.dk:publications/cbfa6343-30af-49f5-9ba4-fbb20727de56

Provided by: Copenhagen University Research Information System